CureVac NV (CVAC)
5.12
-0.09
(-1.73%)
USD |
NASDAQ |
Dec 09, 16:00
5.135
+0.02
(+0.29%)
After-Hours: 20:00
CureVac EPS Diluted (Quarterly): 1.414 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioNTech SE | -0.1395 |
| Immatics NV | -0.4859 |
| Evotec SE | -0.1417 |
| InflaRx NV | -0.2115 |
| Anbio Biotechnology | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 319.28M |
| Revenue (Quarterly) | 63.26M |
| Total Expenses (Quarterly) | -256.02M |
| Enterprise Value | 705.18M |
| Gross Profit Margin (Quarterly) | 91.57% |
| Earnings Yield | 13.96% |
| Normalized Earnings Yield | 14.05 |